This inhibition contributes to Insulin resistance and the metabolic syndrome in obese mice [13], suggesting that chronic inflammatory processes (which result in activation of JNK signaling) are central to the etiology of metabolic diseases in obese individuals [9]. This evidence concerns the gene MAPK8 and Insulin resistance.